Promising New Drugs for Multiple Sclerosis

Multiple sclerosis is a chronic disease resulting from damage of central nervous system. Treatments of MS is meant to manage its course, slowing down the progression of MS, minimizing its symptoms during its flare-ups.  As a result, the patients can get both physical and mental improvements. Of all the treatments of MS, the following five drugs are the most promising and effective.

No.1 Gilenya (fingolimod)
A relapsing form of MS always starts its treatment with Gilenya, the first oral FDA-approved disease-modifying drug in 2010. It is conducive to reducing almost half relapses and dragging its progression.

No.2 Teriflunomide (Aubagio)
Teriflunomide was approved as disease-modifying medications of MS in 2012. According to the New England Journal of Medicine, teriflunomide once a day is significantly helpful to slower MS’ progression.
AS the second oral medication for MS with FDA’s recognition, teriflunomide leads to fewer relapses.

No.3 Dimethyl fumarate (Tecfidera)
Dimethyl fumarate, comes as the third oral disease-modifying drug for MS in March of 2013.It is designed for relapsing-remitting MS (RRMS), and twice-daily doses for this condition are recommended.
In addition to the relieving on immune system’s self-attacking, dimethyl fumarate shares a similar protective effect on the body as antioxidants.

No.4 Dalfampridine (Ampyra)
Dalfampridine is a potassium channel blocker. According to the
Lancet, it speeds up walking of MS patients. Furthermore, patients with improvement in walking speed feel that they get more strength on their leg muscles.

No.5 Alemtuzumab (Lemtrada)
Alemtuzumab was firstly approved to be a treatment for leukemia. It breaks down the CD52 on the surface of the immune cells. Owing to its serious side effects, the FDA recommends that it should be used after inadequate responses from other MS treatments.

These five are the most effective drugs for a better MS management. You can take them as good examples for your family and friends. However, effective MS treatments differ from person to person. Patients with MS should choose the most suitable according to their conditions.